Table. Numbers of Tests, Biopsies, Overdiagnoses, and Curative Treatments per Life Saved for Screening Strategies With Selected Testing Ages Projected by the MISCAN and FHCRC Models.
Age, y | Tests/life saved | Biopsies/life saved | Overdiagnoses/life saved | Treatments/life saved | ||||
---|---|---|---|---|---|---|---|---|
MISCAN model | FHCRC model | MISCAN model | FHCRC model | MISCAN model | FHCRC model | MISCAN model | FHCRC model | |
45 | 1144 | 2305 | 2.6 | 2.7 | 0.6 | 0.1 | 29.8 | 14.6 |
50 | 395 | 518 | 2.3 | 2.5 | 0.6 | 0.1 | 11.4 | 4.4 |
55 | 202 | 157 | 2.3 | 3.0 | 0.7 | 0.3 | 6.2 | 1.8 |
60 | 84 | 74 | 2.6 | 3.8 | 0.9 | 0.5 | 2.8 | 1.2 |
45 And 55 | 381 | 301 | 2.4 | 2.8 | 0.7 | 0.2 | 5.5 | 1.8 |
50 And 60 | 151 | 134 | 2.6 | 3.7 | 0.9 | 0.4 | 2.4 | 1.2 |
Abbreviations: FHCRC, Fred Hutchinson Cancer Research Center; MISCAN, Medical Center Microsimulation Screening Analysis.